Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Nippon India Pharma Fund · Regular ✕Edelweiss Financial Services Fund · Regular ✕

Growth of ₹10,000

Basics

Nippon India Pharma FundEdelweiss Financial Services Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseNippon IndiaEdelweiss
NAV₹591.2429₹10.1025
NAV date20 Nov 202620 Nov 2026
History20.6 years9 months
Expense ratio1.8%2.6%
Stars★★★★★Not rated
Growth Score78.10—

Returns

Nippon India Pharma FundEdelweiss Financial Services Fund
1 month+11.32%+12.05%
3 months+3.52%+5.81%
6 months+8.09%+10.16%
YTD+16.05%—
1 year+14.27%—
3 years (CAGR)+16.91%—
5 years (CAGR)+14.37%—
10 years (CAGR)+15.58%—
Since launch+17.64%+0.59%

Risk

Nippon India Pharma FundEdelweiss Financial Services Fund
Volatility14.1%—
Downside volatility9.1%—
Sharpe0.74—
Sortino1.15—
Calmar1.14—
Return / risk1.20—
Deepest fall−47.36%−15.95%
Days to recover301234
Below its high+0.00%+0.00%

Against benchmark

Nippon India Pharma FundEdelweiss Financial Services Fund
Alpha−2.75%—
Beta0.89—
R²89.5%—
Up capture83.5%—
Down capture91.2%—
Tracking error4.8%—
Information ratio−0.88—
Treynor0.11—

Consistency

Nippon India Pharma FundEdelweiss Financial Services Fund
Best 1-year+175.79%—
Middle 1-year+13.84%—
Worst 1-year−36.67%—
1-year periods with a loss23.4%—
Middle 3-year+20.93%—
Positive months63.9%—
Best day+3.40%+5.24%
Worst day−3.21%−3.48%
Worst 5% day−1.38%−2.08%
Positive days53.7%50.5%
NAVs a year247187

SIP of ₹10,000 a month

Nippon India Pharma FundEdelweiss Financial Services Fund
5-year XIRR+17.18%—
5-year value₹9,29,284—
3-year XIRR+13.26%—
1-year XIRR+21.05%—

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth